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ABSTRACT: The production of well-defined and reproducible poly-
meric nanoparticles (NPs), in terms of size and stability in biolog-
ical environments, is undoubtedly a fundamental challenge in
the formulation of novel and more effective nanomedicines. The
adoption of PEGylated lactide (LA) block copolymers as biode-
gradable and biocompatible nanocarriers at different clinical
stages has rendered these materials an attractive polymeric plat-
form to be exploited and their formulation is further understood.
In the present work, we synthesized a library of linear polyethyl-
ene glycol-poly(D,L-lactide) block copolymers with different
lengths of LA (15, 25, 50, and 100 LA units) via simple and metal-
free ring-opening polymerization, in order to alter the amphi-
philic balance of the different macromolecules. The produced
polymers were formulated into NPs while varying a series of key
parameters in the solvent displacement process, including
solvent:nonsolvent ratios and the nature of the two media, and
the effect on size and stability was assessed. In addition, stability
to protein–NPs interaction and aggregation was studied,
highlighting the different NP final properties according to the
nature of the amphiphilic balance and nanoformulation condi-
tions. Therefore, we have illustrated a systematic and methodo-
logical process to optimize a series of NPs parameters balancing
particle size, size distribution, surface charge, and stability to
guide future works in the nanoformulation field. © 2019 The
Authors. Journal of Polymer Science Part A: Polymer Chemistry
published by Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym.
Chem. 2019, 57, 1801–1810
KEYWORDS: block copolymers; nanoformulation; NP size; NP
stability; PEG-PDLLA
INTRODUCTION The use of nanoparticles (NPs) for drug deliv-
ery is a rapidly growing field, with nanomedicines showing great
promise to improve the clinical outcomes for a range of dis-
eases.1 Encapsulation or tethering of small molecule therapeu-
tics within NPs can result in improved solubility, stability, and
blood circulation times, and ultimately enhance bioavailability.2
Polymeric NPs are of particular interest as their physicochemi-
cal properties can be readily tuned, allowing the polymer struc-
ture and chemistry, as well as ultimate NP size and stability, to
be modified on demand to precisely meet the requirements of
each application.3 In this regard, tailoring the size of NPs is a
crucial design strategy, as physical size can dictate the in vivo
fate of NPs following administration. For systemic administra-
tion, controlling the NP size to within circa 5–200 nm minimizes
the premature clearance of particles through renal filtration
(<5 nm) or by excessive liver and spleen accumulation
(>200 nm).4,5 In addition, studies have shown that controlling
particle size to less than 100 nm can aid prevention of serum
protein attachment, thus enhancing NP stability and prolonging
blood half-lives.6 In cancer drug delivery, the long circulation
times of large-sized NPs further improve preferential accumula-
tion within tumor sites as a result of enhanced permeation
through leaky blood vessels, typical for rapidly growing solid
tumors.7 On the other hand, smaller sized NPs (<50 nm) show
Additional supporting information may be found in the online version of this article.
© 2019 The Authors. Journal of Polymer Science Part A: Polymer Chemistry published by Wiley Periodicals, Inc.
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enhanced extravasation, tissue penetration across multiple cell
layers, and cellular uptake, particularly in the cases of slow-
growing or heterogeneous tumors that do not present with sig-
nificant vascular fenestrations.8–10 Finally, size requirements for
NPs to cross biological barriers such as the blood–brain barrier,
or for targeting toward specific organs, are also factors to be
accounted for in NP design.11,12 Therefore, it is imperative to be
able to precisely tune the physical characteristics of the
nanomedicine carrier for each specific drug delivery scenario.
Critically, in the interests of ultimate translation of nan-
omedicines into the clinic, one of the main challenges to be over-
come is the ability to achieve these tailored aspects of polymeric
NPs, while at the same time facilitating scalability and cost-
effectiveness for the pharmaceutical industry. It is of crucial
importance to reduce synthetic complexity, tedious purification
steps, the number of different components, and addition of toxic
surfactants in order to maintain batch-to-batch consistency, clin-
ical relevance, and patient safety. One widely used approach in
this regard is to employ amphiphilic block copolymers as the
carrier materials, as they can inherently self-assemble into NPs
in an aqueous environment without the use of additional stabi-
lizers. Specifically, incorporating hydrophilic segments such as
polyethylene glycol (PEG) provides a hydrophilic corona that
can impart the final formulation with stability in biological envi-
ronments, and biodegradable hydrophobic segments, such as
D,L-lactide (LA) and D,L-LA-co-glycolide, provide a hydrophobic
core region that can facilitate encapsulation and release of active
agents. This strategy is well exemplified by several clinically rel-
evant nanomedicines based on poly(D,L-lactide) (PDLLA),
including the FDA-approved Genexol-PM for delivery of pacli-
taxel, and the BIND-014 and Accurins technologies currently in
Phase I and II clinical trials.6,13,14
PDLLA and its copolymers are routinely synthesized through
ring-opening polymerization (ROP); a powerful, simple, and ver-
satile technique. However, a major drawback with LA-based
polymers and copolymers is the toxic catalyst and stringent reac-
tion conditions typically utilized in their production.15–17
Recently, we demonstrated a more friendly catalytic
approach for ROP of LA in ambient conditions and at room
temperature,18–20 using mild organocatalysts such as 1,8-
diazabicyclo[5.4.0]undec-5-ene (DBU).21–24 This synthetic
approach negates the need for toxic catalysts, high tempera-
ture reactions (over 120C), and more extensive purifica-
tions, thereby facilitating further access to these materials
across nonspecialist chemical laboratories.
Employing PEG as the ROP initiator results in the production
of amphiphilic materials in a single step, where the ratio of
the hydrophilic and hydrophobic components can be readily
tuned. Due to their intrinsic amphiphilic balance, PEGylated
block copolymers are perfect candidates to be formulated into
NPs via simple nanoprecipitation techniques. In this regard,
previous studies have demonstrated that the amphiphilic bal-
ance of the copolymers can impact the size, stability, surface
charge, and protein corona formation on the final NPs.25 How-
ever, there are a series of physicochemical parameters that
drive the nucleation, growth, and aggregation of the polymers
into NPs during the nanoprecipitation process that have not
yet been fully understood.26 Comprehension of the relation-
ship between these parameters and their quantitative effects
on NP formation via nanoprecipitation could be an invaluable
tool in the translation of this methodology on a larger scale.
Based on this, in the present work, we aimed to systematically
study the factors that influence the nanoformulation process of
PEG-PDLLA copolymers. The ability to modulate, on demand,
the final NP size and stability simply through tuning the formu-
lation parameters is a potential strategy to achieve optimum
physical characteristics without requiring the synthesis of new
polymers each time. While investigations into the self-
assembly behavior of PLGA and PCL polymers have been ana-
lyzed and reported in detail in previous literature,26–29 as well
as one example of a PEGylated block copolymer (poly(ethylene
glycol)-b-poly(N-2-benzoyloxypropyl methacrylamide) (mPEG-
b-p(HPMA-Bz)), to our knowledge, this process has not been
explored in detail for PEG-PDLLA polymers.30 Therefore, to
provide important insights into the tunable parameters that
influence self-assembly of these clinically relevant materials,
this work presents a complete study of NP formation and
assessment of stability. We screened the self-assembly, NP size,
and stability of a library of PEG-PDLLA copolymers with varied
lengths of the hydrophilic and hydrophobic blocks, evaluating
the magnitude of impact of changing the amphiphilic balance
of the polymer and the precipitation solvent, nonsolvent, and
their respective ratios. In addition, with the intention to
expand the screening procedure toward prebiological in vitro
evaluation, we developed a DLS-based assay to assess the sta-
bility of the resultant NPs against protein-induced aggregation
using bovine serum albumin (BSA) as a model serum protein.31
Therefore, this work provides vital and concise strategies for
modulating NPs formation from a highly exploited polymeric
material such as PEG-PDLLA, for a variety of self-assembly and
pharmaceutical applications.
EXPERIMENTAL
Materials
Poly(ethylene glycol) methyl ether (Mn = 5000 or 2000 Da) and
DBU (98%) were purchased from Sigma-Aldrich, UK. Dic-
hloromethane (DCM, 99.8%, extra dry over molecular sieve,
stabilized, Acroseal) was purchased from AcrosOrganics, UK. DL-
LA (99%), acetone, acetonitrile (ACN), and THF were purchased
from Fisher Scientific, UK. All chemicals were used as obtained
without additional purification unless otherwise stated.
PEG-Initiated Ring-Opening Polymerization of Lactide
Block Copolymer
A representative synthesis of mPEG5000-LA15 was as follows.
A predetermined amount of PEGylated chain initiator and DL-
LA were directly weighed out (1.00 g of LA and 2.31 g of
mPEG5000) in a glass vial (dried in an oven at 100C over-
night) and capped. Dry DCM (5 mL) was added and the mix-
ture was allowed to dissolve at room temperature. DBU (3%
w/w with respect to the amount of LA) was directly added to
the reaction mixture to catalyze the ROP. After 15 min, the
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polymerization was quenched by adding the solution
dropwise into cold hexane (30 mL) and the polymer was puri-
fied via multiple precipitation steps in hexane and diethyl
ether. Finally, the polymer was dried under vacuum (conver-
sion of monomer into polymer ~75–80% w/w). A final NMR
spectrum was recorded of the products postpurification. The
library of copolymers were achieved by adjusting the initial
[M]/[I] ratio in order to target the desired length of LA. 1H
NMR (400 MHz, CDCl3, ppm): δ 5.19 (broad m, xH), 3.67
(broad s, 356H), 3.3 (x) 1.65–1.47 (2 asymmetric broad s,
53 + 78H).
Nanoparticle Preparation
A nanoprecipitation, or solvent displacement, method was
used to form NPs. In particular, polymer (10 mg) was dis-
solved in either acetone, THF, or ACN (volume adjusted
according to the organic solvent/aqueous medium ratio). The
polymeric solution was added either by hand or by an auto-
matic pump to deionized water (10 mL, within 30 s), under
constant stirring at 550 rpm. The polymers rapidly formed NP
suspensions through solvent exchange between the aqueous
medium and the organic solvents. The final suspension was
then left stirring for 24 h at room temperature in order to
reach complete organic solvent removal via evaporation.
Protein Binding Assay
To determine protein corona association to the NPs, binding
studies were undertaken using BSA as the model protein. Each
NP (1 mg/mL in PBS) and BSA alone (2 mg/mL in PBS) was
sized by DLS at a fixed attenuation. BSA was added (150 μL) to
NPs (150 μL) (final conc. NPs:500 μg/mL, BSA: 0.2 wt %
[equivalent to culture media+10% FBS]). The samples were
incubated at 37C and size measurements of the samples were
taken by DLS on a Zetasizer after 1, 24, and 48 h. BSA was pre-
pared as a stock solution in PBS at 4 mg/mL.
General Methods and Instrumentation
NMR: Bruker AV400 and AV3400 NMR spectrometers operat-
ing at 400 MHz (1H) and 101 MHz (13C) at ambient tempera-
ture were used to perform NMR analysis in deuterated
solvents. Chemical shifts were assigned in parts per million
(ppm). 1H NMR chemical shifts (δH) are reported with the
shift of CHCl3 (δ = 7.26 ppm) as the internal standard when
CDCl3 was used.
13C Chemical shifts (δC) are reported using
the central line of CHCl3 (δ = 77.0 ppm) as the internal stan-
dard. All spectra were obtained at ambient temperature
(22C  1C). MestReNova 6.0.2 copyright 2009 (Mestrelab
Research S. L.) was used for analyzing the spectra.
FTIR: FTIR spectroscopy was performed in the range of
4000–650 cm−1. This was carried out using a Bruker Tensor
27 FTIR spectrophotometer using an ATR attachment. Spectra
were analyzed using the MicroLab software.
GPC: GPC was used for determination of number average
molecular weight (Mn), weight average molecular weight
(Mw), peak molecular weight (Mp), and molecular weight dis-
tribution (dispersity, Ð, Mw/Mn). The analysis was performed
using an Agilent 1260 Infinity Series HPLC (Agilent Technolo-
gies) fitted with two Agilent PL-gel Mixed-C columns in series
at a flow rate of 1 mL min−1 using THF (HPLC grade, Fisher
Scientific) as eluent at room temperature and a differential
refractive index detector. Poly(methyl methacrylate) standards
(Mn range: 1,800,000–505 g mol
−1) and polycaprolactone stan-
dards were used for calibration.
DSC: Thermal properties of the materials were studied by DSC
(Q2000, TA Instruments, Leatherhead, UK) at a heating rate of
10C/min.
DLS: The particle size and zeta-potential were analyzed by
DLS using a Zetasizer Nano ZS (Malvern Instruments Ltd).
Measurements were taken in triplicate of NPs suspensions at
1 mg/mL in milliQ water and used to calculate average inten-
sity particle size distributions.
TEM: TEM samples were prepared as follows; the sample in
aqueous suspension (13 μL) was added to a copper grid
(Formvar/carbon film 200 mesh copper [100]). The sample
was left on the grid for 10 min and then the excess was
removed using filter paper. The grid was allowed to dry under
a fume hood for a minimum of 30 min prior to use. TEM
images were captured using the FEI Biotwin-12 TEM
equipped with a digital camera at the Nanoscale and Micro-
scale Research Centre of the University of Nottingham.
RESULTS AND DISCUSSION
Polymer Synthesis and Characterization
A metal-free ROP synthetic strategy catalyzed by DBU in ambi-
ent conditions was employed for the synthesis of PEGylated
block copolymers, in order to generate amphiphilic copolymers
in a single, fast, reaction step with minimal purification require-
ments (Fig. 1A). Two different mPEG chains, mPEG2000 and
mPEG5000, were used as macroinitiators to produce a library of
mPEG-PDLLA block copolymers, varying the initiator to mono-
mer ratios to generate different LA chain lengths, namely
15, 25, 50, and 100 LA units. Monomers reached quantitative
conversion into polymers (>98% mol/mol) within 15 mins,
independently of the length of the initiator and the mono-
mer/initiator ratio. The resultant polymers were fully charac-
terized, with 1H NMR of the purified copolymers showing the
characteristic peaks of the polymerized LA in agreement with
the monomer and initiator feed ratios as reported in Table 1
and Supporting Information Figure S1. Figure 1C depicts a rep-
resentative series of stacked 1H NMR spectra to exemplify the
nature of the typical peaks. In addition, the ATR-IR spectra
show all the characteristic transitions of alkyl, ester, and ether
moieties, further confirming the successful copolymerization
(Fig. 1B). Control of the polymerization in terms of final molec-
ular weight (in close agreement with the number of units
observed in the 1H NMR spectra) and dispersity (all the values
<1.2) was confirmed by GPC analysis, as reported in Table 1
and Supporting Information Figure S2. Thermal analysis of the
block copolymers was performed using DSC with one single
heating ramp and was carried out from −20 to 120, and for
all the block copolymers, a single endothermal peak was
JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2019, 57, 1801–1810 1803
JOURNAL OF
POLYMER SCIENCE WWW.POLYMERCHEMISTRY.ORG ORIGINAL ARTICLE
observed (Supporting Information Fig. S3). The Tm values cal-
culated from the DSC thermographs are presented in Table 1,
where the polymers were observed to have melting points due
to the crystalline nature of the PEG initiators (Supporting Infor-
mation Fig. S3). The melting temperatures gradually decreased
on trend with increasing LA chain length, which was attributed
to the amorphous and hydrophobic PDLLA chains hindering
the chain-packing nucleation step during the cooling cycle. No
clear glass transitions could be observed, likely due to the
sharp and intense melting transition obscuring the Tg step.
Evaluation of Varying Formulation Approach and
Concentration on Nanoparticles Size
With the view to simplify and validate the formulation strat-
egy in this work, an experiment was performed to compare
the formation and final size of the nanoaggregates as a result
of nanoprecipitation by syringe pump versus by hand-held
pipetting (Fig. 2A). The block copolymers mPEG2000-LA100 and
mPEG5000-LA100 were used as the representative polymers for
this experiment, with nanoprecipitation from acetone into
H2O (final concentration of 1.
mg/mL). Figure 2A depicts the NPs size from both processes
as measured by DLS, confirming that the particles produced
had no statistical difference in final size within the same sub-
set. The absence of any variations in the average size aligns
with previously reported observations32 when the traditional
hand-held process was compared with a fully miniaturized
printing approach. This observation may be attributed to the
small volume of organic solvent adopted (1–2 mL) per formu-
lation, as well as the high rate of addition to the aqueous
FIGURE 1 (A) Reaction scheme for DBU-catalyzed mPEG-OH-initiated LA polymerization. (B) ATR-IR stacked spectra of three
PEGylated copolymers as examples of the library of materials; main characteristic vibrations are underlined. (C) 1HNMR stacked
spectra of the entire mPEG2000 subset of purified block copolymers; main characteristic peaks are highlighted. [Color figure can be
viewed at wileyonlinelibrary.com]
TABLE 1 Chemical Characterization of the PEGylated Copolymers
Copolymer
Feed Ratio
(PEG:LA) mol %
Composition (1H NMR)
(PEG:LA) mol %
Mn (
1H NMR)
(Da)
Mn (GPC)
(Da)a Đ (SEC)
%PEG/PLA
(hydrophilic wt%) Tm (C)
mPEG2000-LA15 1:15 1:16 4300 7300 1.2 48 47.0
mPEG2000-LA25 1:25 1:26 5700 13,500 1.2 36 45.9
mPEG2000-LA50 1:50 1:51 9300 14,700 1.1 22 43.7
mPEG2000-LA100 1:100 1:102 17,000 20,000 1.2 12 41.6
mPEG5000-LA15 1:15 1:15 8300 8300 1.2 70 58.4
mPEG5000-LA25 1:25 1:26 9000 16,000 1.1 58 55.4
mPEG5000-LA50 1:50 1:52 13,000 19,000 1.1 41 54.1
mPEG5000-LA100 1:100 1:104 20,000 24,000 1.2 26 48.4
a GPC values compared to PMMA standards.
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phase (entire addition process within 30 s). NP sizes were
also confirmed to remain unchanged when the final concen-
tration in the aqueous environment was adjusted within an
order of magnitude (0.5–5 mg/mL) (Fig. 2B). This behavior
was also in agreement with previous work,32 concerning a
series of random and block copolymers nanoformulated
within a similar concentration range as explored here. Due to
the absence of any concentration effects, a final NP concentra-
tion of 1 mg/mL was selected for all future experiments for
simplicity. During the NP formation screening process, only
formulations that resulted in monomodal samples as mea-
sured by DLS were considered to be successful, and therefore
reported. Supporting Information Figure S4 demonstrates the
typical classification of good (accepted) and poor (rejected)
samples to exemplify our applied threshold, and Supporting
Information Figure S5 summarizes all of the self-assembly
experiments and our applied selection criteria. In this way,
any missing values throughout the manuscript represent
either a lack of self-assembling or the presence of multiple
peaks, unless stated differently.
Nanoprecipitation from Acetone, THF, and ACN into H2O:
Effect of Hydrophobic Block Length and Organic Solvent
The first screening process aimed to identify the relationship
between NP sizes when the length of the hydrophobic block
was varied from 15 units to 100 units of LA. Additionally, the
nanoprecipitation process was performed exploring three dif-
ferent organic solvents (acetone, THF, and ACN) at the same
ratio of solvent:nonsolvent (1:5), in order to elucidate any
additional solvent effects on the final size and PDI of the NPs.
NP measurements were performed a minimum of 24 h after
the nanoformulation process in order to ensure full removal
of the organic solvent from the final samples. Initially, a series
of formulations were prepared and periodically analyzed by
DLS over a 72-h period. No change in the NP size or evidence
of solvent-induced aggregation was observed during this
experiment, thus confirming that all the subsequent analysis
was in a pure aqueous environment.
It can be seen in Figure 3 that the LA chain length had a mar-
ked effect on the NP size when the PEG length remained
unchanged, particularly for the mPEG2000 polymer series. NPs
assembled from the mPEG2000-LA15 polymer resulted in NPs
of circa 100 nm with a PDI of around 0.2, with small varia-
tions in size as the organic solvent was changed (acetone:
88 nm; THF: 101 nm; ACN: 113 nm). However, increasing the
size of the LA block to 50 units caused a substantial decrease
in NP size to circa 30 nm, while the PDI remained at 0.2.
Increasing the length of the hydrophobic block further to
100 units of LA resulted in NPs of a comparable size to the
15 units, but with a decrease in the PDI of the particles down
to 0.1, indicating that the longer hydrophobic block may con-
tribute to both the improvement of particle size due to steric
effects as well as enhanced LA packing within the NPs core.
The mPEG5000 series had a similar trend, with the 50 units of
LA consistently producing the smallest particle size (circa
30 nm) from all solvents.
However, in this case, the choice of organic solvent had a
more tangible effect on the resultant size for the other LA
lengths; mPEG5000-LA15 varied from 35 nm (THF) to 82 nm
(ACN), and mPEG5000-LA100 varied from 35 nm (ACN) to
80 nm (THF). In general, the final PDI values for the mPEG5000
series were larger than mPEG2000; however, it could still be
observed that the 100 units of LA consistently had the
smallest PDI. To further explore the solvent effects, the experi-
ments were repeated varying the solvent:nonsolvent ratio to
1:2.5 and 1:1 (Supporting Information Fig. S6). Increasing the
amount of organic solvent within the nanoformulation process
to 1:1 only produced suitable NPs in certain cases: no stable
NPs could be produced from mPEG2000-LA50 or from ACN in
general at this ratio, and THF was successful only for the
mPEG5000 series. However, the resultant particles were large
(>200 nm), although the PDI was narrow (0.04–0.15).
Nanoprecipitation from acetone resulted in large particles
with a narrow PDI for the mPEG2000 polymers (>200 nm, PDI
FIGURE 2 (A) NPs size (nm) of NPs prepared by hand versus by
syringe pump; no statistical differences were observed
(mean  SD, error bars represent SD from three different
replicate batches). (B) Trend in NPs sizes at different
concentrations (from 0.5 to 5 mg/mL) (mean  SD, error bars
represent SD from three different replicate batches). No
statistical differences within the mPEG2000-LA100 and mPEG5000-
LA100 subsets were observed when using a one-way ANOVA
with Dunnett’s post hoc test (P < 0.05). [Color figure can be
viewed at wileyonlinelibrary.com]
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<0.12) and large particles with a broad distribution for the
mPEG5000-LA15 (170 nm, PDI 0.4). Small NPs with a broad dis-
tribution were produced from the mPEG5000 with 25 and
50 units of LA (32 nm, PDI 0.34). The intermediate solvent
ratio of 1:2.5 had a less pronounced effect, and particles were
produced from all conditions (except for mPEG2000-LA50 and
mPEG5000-LA15 with ACN). On average, the mPEG2000 series
had a particle size of >100 nm and a narrow PDI, with the
exception of LA50, which reduced to around 40 nm. The
mPEG5000 series had an overall trend of small particle size
(25–50 nm) with the exception of LA15 at 150 nm from THF,
with PDI values varying from 0.08 up to 0.4. From these
results, it could be concluded that acetone was the best sol-
vent choice for PEG-LA block copolymers in terms of sizes
below 100 nm and PDI below 0.2 for most cases, and that
nanoprecipitations performed from a fast addition process
resulted in ideal NPs when employing a solvent:nonsolvent
ratio of 1:5. However, it was demonstrated that variations in
particle size could successfully be obtained from the same
polymer simply as a consequence of changing the parameters
of nature of organic solvent and solvent:nonsolvent ratio, giv-
ing an indication of NP tunability.
Nanoprecipitation from Acetone, THF, and ACN into PBS:
Effect of Presence of Salts
The experimental series from above was next repeated using
PBS as the nonsolvent in place of H2O, in order to examine
the effect of salt presence on the NP size, as it is known that
screening of any surface charges by salts can influence NP size
and stability. Figure 4 demonstrates that the overall trend for
the mPEG2000 series was the production of NPs of approxi-
mately 100–150 nm in size, with no significant variations
compared with the data from H2O. The solvent ratio of 1:1
(from acetone) increased the NP size to >200 nm, and THF
could reduce the NP size to around 40 nm for LA50 at the 1:5
and 1:25 ratio. PDI values also showed a similar trend,
remaining approximately 0.2–0.3 for most samples. As above,
the mPEG5000 series produced NPs that were generally
smaller than the mPEG2000, with most conditions producing
particles <80 nm. However, there was also an overall trend of
larger particles as a result of nanoprecipitation into PBS com-
pared with H2O. For the mPEG5000-LA15, the presence of salts
within the nonsolvent caused an increase in overall particle
size at the 1:5 ratio (acetone: 100 nm, THF: 85 nm, ACN:
150 nm) with the same size trend as in H2O (acetone: 64 nm,
THF: 36 nm, ACN: 82 nm). This was also observed for the
LA25 at the 1:5 and 1:2.5 ratios, with an increase in the NP
size by around 20–50 nm in all conditions.
Variation in Nanoparticle Zeta Potentials as an Effect of
Formulation Conditions
Based on the observations that modifying the organic solvent
and solvent:nonsolvent ratios affected the particle size and size
distribution, we next investigated how these parameters could
also affect surface charge, or zeta potential, of the NPs. The zeta
potential is known to influence NP behavior in biological envi-
ronments, both in terms of stability of the polymer suspension
as well as interactions with proteins in the body.33,34 A slightly
negative zeta potential (from neutral to −30 mV) should confer
polymeric NPs with resistance to aggregation and reduced
interactions with proteins. Zeta potential measurements were
performed after nanoprecipitation into milliQ H2O from ace-
tone, THF, and ACN at the 1:5 and 1:2.5 ratios (Fig. 5). In all
the cases, the zeta potential was negative, as expected for
PEGylated copolymers; however, the nanoprecipitation condi-
tions could modulate this value from −12 mV down to
−33 mV, depending on the polymer. For the PEG2000-LA15, NPs
formed at the 1:5 versus 1:2.5 ratio resulted in the size increas-
ing by up to 50 nm depending on the organic solvent, and this
was reflected in a change in zeta potential trending toward
neutral (acetone: −22 mV to −12 mV; THF: −19 mV to
−16 mV; ACN: −25 mV to −17 mV). In general, nano-
precipitation conditions that produced small particles (less than
50 nm) had the more negative zeta potential. This was
observed for the mPEG2000-LA50, at both 1:5 and1:2.5 ratios,
FIGURE 3 NP size and PDI as an effect of hydrophilic:hydrophobic balance (length of mPEG initiator and units of LA) when
nanoformulated in three different solvents at the same solvent:nonsolvent volume ratio (1:5) (mean  SD, error bars represent SD
from three different measurements). Measurements were performed in pure water after full removal of the organic solvent. [Color
figure can be viewed at wileyonlinelibrary.com]
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where the particle sizes of circa 30 nm had zeta potential
values of circa −30 mV.
In contrast, the mPEG2000-LA15 (hydrophilic 48%) with parti-
cle sizes of >100 nm at the 1:2.5 solvent:nonsolvent ratio had
a zeta potential of circa −12 mV. There was also a clear corre-
lation between the amphiphilic balance of the block copoly-
mers and the zeta potential, where the block copolymers with
a lower hydrophilic block% had more negative surface poten-
tials. This was exemplified for the mPEG2000-LA100, which had
the lowest percentage of PEG (12%) and the lowest zeta
potential at circa −33 mV. We speculate that this is a result of
the shorter PEG lengths providing a more extended brush
conformation on the NP surface, and thus enhanced
charge/surface area properties.
Stability of Nanoparticles in Presence of BSA
Finally, to further evaluate the stability of the produced NPs
as an effect of size and surface charge in biologically relevant
conditions, a screening assay was developed using DLS with
BSA as the model protein to assess protein-induced aggrega-
tion.31 A DLS-based assay was chosen as the preliminary
screening technique due to the fast response time and ease of
detection of aggregation within each sample. The mPEG2000
library (nanoprecipitated from acetone into H2O ratio 1:5)
was selected as representative polymers, to evaluate in com-
parison with the zeta potential analysis from above.
NPs were incubated with 0.2 wt % of BSA at 37C to represent
protein concentrations within in vitro conditions.35 It could be
seen from the DLS traces that all NPs in this experiment initially
had monomodal size distributions in accordance with the screen-
ing described above. Importantly, the NPs also remained stable
over time in the presence of BSA with a little or no observed par-
ticle aggregation (Fig. 6). Taking into account the results of sur-
face charge from Figure 5, a correlation between zeta potential
and the stability of the particles over time in presence of albumin
can be proposed. The mPEG2000-LA15 had a zeta potential of circa
−20 mV, and was observed to be moderately stable from this
experiment, with some broadening in the peak after 48 h. How-
ever, the 50 and 100 units of LA, with zeta potentials of circa
−30 mV, demonstrated improved stability, with virtually
unchanged DLS traces over the course of the experiment. As a
comparison, we also analyzed the stability of a large particle with
broad PDI value, mPEG5000-LA15 (hydrophilic ratio 70%), to
ascertain the impact of a more neutral zeta potential in these
conditions (−5.8 mV, data not shown). It can be seen in
Supporting Information Figure S7 that this formulation initially
had a bimodal size distribution in accordance with the screening
experiments above, which likely contributed to the observed
instability of the particle in the presence of the BSA during obser-
vation. The DLS traces depict evidence of aggregation by 24 h,
and increasing by 48 h, potentially as a result of the relatively
short core-forming hydrophobic block and reduced charge den-
sity as confirmed by the zeta potential close to neutral.
To corroborate this speculation of the link between size,
charge density, and narrow PDI on particle stability in the
presence of BSA, we finally analyzed the change in zeta poten-
tial of the four NPs when exposed to increasing salt conditions
(25, 150, and 250 μg/mL NaCl). PEGylated polymers typically
demonstrate a negative zeta potential arising from cations
associating with the oxygen lone pairs on the PEG chain caus-
ing a loose surface shell of counter anions when in solution.
Addition of NaCl screens these surface charges, causing the
zeta potential to neutralize.36 A trend between the zeta poten-
tial in pure water and rate and extent at which the surface
charge neutralized could be observed between the four NPs. It
was observed that the mPEG5000-LA15 that was not stable to
BSA had a rapid change with increasing concentration of NaCl
and reached 97% of neutralization. Importantly, the mPEG2000
with 50 and 100 units of LA, with starting zeta potentials of
circa −30 mV, showed the slowest change over NaCl concentra-
tion, reaching a final neutralization of 87% (Supporting Infor-
mation Fig. S8). The mPEG2000-LA15, starting from −22 mV,
showed a slightly more rapid neutralization; however, it
FIGURE 4 NPs size and PDI as an effect of hydrophilic:hydrophobic balance (length of mPEG initiator and units of LA) when
nanoformulated in three different solvents at different solvent:nonsolvent ratios into PBS (mean  SD, error bars represent SD from
three different measurements). Measurements were performed in PBS after full removal of the organic solvent. [Color figure can be
viewed at wileyonlinelibrary.com]
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reached only the same 87% final value. The higher concentra-
tion of salt required to effectively screen the surface charges
for the more stable NPs was attributed to their higher charge
density, and conversely, in the case of the mPEG5000-LA15, the
NaCl was able to effectively screen the surface potential at a
lower concentration.
The reported screening of NP formation and stability in this
work has remarked not only the importance of the formula-
tion strategy employed, but also the interplay among particle
size, size distribution, and charge density to effectively link
NP physical characteristics with stability in biologically rele-
vant conditions.
CONCLUSIONS
The present work investigated fundamental nanoformulation
parameters such as the nature of organic solvent, nature of
aqueous environment, ratio between solvent:nonsolvent, final
NP concentration, reproducibility of hand-held simplified for-
mulation strategies, as well as the ratio of hydrophobic:hydro-
philic block of a small set of nanoformulated mPEG-PDLLA
FIGURE 6 Protein binding studies showing representative DLS traces of NPs after incubation in 0.2 wt% of BSA. NPs showed slight
increases in size and broadening of the size distribution; however, no significant changes or aggregation was observed, confirming
stability in these conditions. [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 5 Zeta potential measurements as an effect of hydrophilic:hydrophobic balance (length of mPEG initiator and units of LA) for
the mPEG2000 library when nanoformulated in three different solvents at different solvent:nonsolvent ratios into H2O (mean  SD,
error bars represent SD from three different measurements). Measurements were performed in pure water after full removal of the
organic solvent (left) solvent:nonsolvent ratio of 1:5 (right) varied solvent ratios (approximate NP size indicated) [Color figure can be
viewed at wileyonlinelibrary.com]
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copolymers. Understanding the behavior of these materials is
of importance as they are chemical analogues of pharmaceuti-
cally relevant polymeric excipients used in commercial nan-
omedicines (Genexol-PM and Accurins). We undertook this
systematic investigation to shed light on the nanoformulation
parameters that influence NP physical properties and stability
to guide future works in the field. It was observed that chang-
ing the organic solvent (acetone, THF, and ACN) and their
ratio with regard to the aqueous phase (H2O and PBS) could
significantly change the final NPs when the same polymer was
used. It was confirmed that the amphiphilic balance of the
copolymer influenced both the size and zeta potential of the
NPs, and ultimately the stability to protein-induced aggrega-
tion in the presence of BSA, whereby block copolymers with
small hydrophilic block% generally demonstrated improved
NP stability. Taking into account the data reported, we have
illustrated a methodological process to optimize important
NPs parameters balancing particle size, size distribution, and
surface charge, to ultimately generate stable and reproducible
NPs based on PEG-PDLLA to guide future work within the
nanoformulation field.
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